Výsledky vyhledávání - "E. A Stadtmauer"

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

Autor: D E, Tsai, C L, Hardy, J E, Tomaszewski, R M, Kotloff, K M, Oltoff, B G, Somer, S J, Schuster, D L, Porter, K T, Montone, E A, Stadtmauer

Publikováno v: Transplantation. 71(8)

Posttransplant lymphoproliferative disorder (PTLD) is an Epstein-Barr virus-associated malignancy that occurs in the setting of pharmacologic immunosuppression after organ transplantation. With the increased use of organ transplantation and intensive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::47705e5c764f157791ea94f8ca9e70d6
https://pubmed.ncbi.nlm.nih.gov/11374406

Zobrazit plný text záznamu

Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer

Autor: S, Visonneau, A, Cesano, D L, Porter, S L, Luger, L, Schuchter, M, Kamoun, M H, Torosian, K, Duffy, C, Sickles, E A, Stadtmauer, D, Santoli

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 6(5)

The human cytotoxic T-cell line TALL-104 displays antitumor effects in animals with implanted and spontaneous malignancies. A Phase I trial was conducted to determine toxicity of TALL-104 cell therapy in women with metastatic refractory breast cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c6324000908ed912bcc699edaaa37fb7
https://pubmed.ncbi.nlm.nih.gov/10815893

Zobrazit plný text záznamu

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

Autor: E A, Stadtmauer, A, O'Neill, L J, Goldstein, P A, Crilley, K F, Mangan, J N, Ingle, I, Brodsky, S, Martino, H M, Lazarus, J K, Erban, C, Sickles, J H, Glick

Publikováno v: The New England journal of medicine. 342(15)

We conducted a randomized trial in which we compared high-dose chemotherapy plus hematopoietic stem-cell rescue with a prolonged course of monthly conventional-dose chemotherapy in women with metastatic breast cancer.Women 18 to 60 years of age who h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::141f3b00fd9f4586d55343cfc950fc9b
https://pubmed.ncbi.nlm.nih.gov/10939900

Zobrazit plný text záznamu

Cerebral spinal fluid involvement by Hodgkin's disease diagnosed by CSF cytology and immunocytochemistry

Autor: L A, Perez-Jaffe, K E, Salhany, R J, Green, T, Griffin, E A, Stadtmauer, P K, Gupta

Publikováno v: Diagnostic cytopathology. 20(4)

A 39-yr-old man with stage IV Hodgkin's disease (HD) involving bone marrow was being evaluated for autologous bone marrow transplantation when he developed diplopia, prompting a lumbar puncture tap for cerebral spinal fluid (CSF) examination. Cytolog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b6aec1be79de0cb43198ae1ea6c38b1c
https://pubmed.ncbi.nlm.nih.gov/10204105

Zobrazit plný text záznamu

Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490)

Autor: C L, Bennett, T J, Stinson, M S, Tallman, E A, Stadtmauer, R W, Marsh, W, Friedenberg, H M, Lazarus, L, Kaminer, R M, Golub, J M, Rowe

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 10(2)

Considerable morbidity and mortality and costs occur during induction therapy for acute myeloid leukemia (AML). Colony-stimulating factors (CSFs) can shorten neutropenia, and may lower costs. We performed a cost-minimization analysis of granulocyte m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5c94a486ba90431cc0b68b03dfc19bc3
https://pubmed.ncbi.nlm.nih.gov/10093686

Zobrazit plný text záznamu

4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement

Autor: J M, Bird, S, Luger, P, Mangan, M, Edelstein, L, Silberstein, W, Powlis, J, Ball, D J, Schultz, E A, Stadtmauer

Publikováno v: Bone marrow transplantation. 18(2)

Between June 1990 and January 1994, 19 patients with non-Hodgkin's lymphoma (NHL) at high risk for bone marrow involvement underwent 4-hydroperoxycyclophosphamide (4-HC) purged bone marrow transplantation. Eleven patients had low grade, seven interme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::db827372a9cdcb3a21ee4d1c3f6245a8
https://pubmed.ncbi.nlm.nih.gov/8864439

Zobrazit plný text záznamu

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)

Autor: J M, Rowe, J W, Andersen, J J, Mazza, J M, Bennett, E, Paietta, F A, Hayes, D, Oette, P A, Cassileth, E A, Stadtmauer, P H, Wiernik

Publikováno v: Blood. 86(2)

The treatment of adult patients greater than 55 to 70 years of age with acute myelogenous leukemia (AML) is associated with a treatment-related mortality of approximately 25%. This prospective, double-blind randomized study was designed to see if the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f7173c96e67eae53578fde854c4e8e6e
https://pubmed.ncbi.nlm.nih.gov/7605984

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání